1. Home
  2. CLMT vs ANIP Comparison

CLMT vs ANIP Comparison

Compare CLMT & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calumet Specialty Products Partners L.P.

CLMT

Calumet Specialty Products Partners L.P.

HOLD

Current Price

$26.72

Market Cap

2.1B

Sector

Energy

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$73.62

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLMT
ANIP
Founded
1916
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
2024
1999

Fundamental Metrics

Financial Performance
Metric
CLMT
ANIP
Price
$26.72
$73.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$21.25
$107.33
AVG Volume (30 Days)
1.3M
285.9K
Earning Date
03-26-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
419.23
EPS
0.04
3.32
Revenue
$4,189,400,000.00
$206,547,000.00
Revenue This Year
$1.18
$44.10
Revenue Next Year
$2.45
$13.18
P/E Ratio
$753.75
$35.93
Revenue Growth
0.20
2.47
52 Week Low
$7.68
$56.71
52 Week High
$30.35
$99.50

Technical Indicators

Market Signals
Indicator
CLMT
ANIP
Relative Strength Index (RSI) 53.72 35.37
Support Level $17.70 $62.89
Resistance Level $29.92 $85.12
Average True Range (ATR) 1.27 2.78
MACD -0.07 -0.30
Stochastic Oscillator 32.53 12.37

Price Performance

Historical Comparison
CLMT
ANIP

About CLMT Calumet Specialty Products Partners L.P.

Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: